$SNDX (L @ 7.5% PW, +109% gain)
Nice red to green move as market digests Q2 call
Revuforj likely losing share in NPM1, but positives outweigh the negative as post-transplant use increases (longer duration, revenues will stack nicely going forward)
Net loss down 44%, inching
